• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Investors applaud ATL’s Q1 results

Article

Ultrasound vendor ATL appears to be one of the few medical imaging firms these days to get an even break in the financial markets. Investors bid the Bothell, WA, company's shares higher on April 24 after the company released financial results that

Ultrasound vendor ATL appears to be one of the few medical imaging firms these days to get an even break in the financial markets. Investors bid the Bothell, WA, company's shares higher on April 24 after the company released financial results that indicated a 6% increase in revenues, although net income was reduced due to expenses associated with the launch of its new HDI 1000 scanner. ATL's stock jumped $3.88, or 13%, to close at $33.25 on April 24.

For the quarter (end-March), ATL had revenues of $100.1 million, compared with $94.8 million in the second quarter of 1996. Net income stood at $2.1 million, compared with $3 million in the same period last year. ATL said that the results for the most recent quarter included launch expenses for HDI 1000, and that it expected launch expenses of $2 million to $4 million in the second quarter.

HDI 1000 uses software in place of hardware to save costs in system manufacturing (SCAN 3/5/97). Orders for the scanner are exceeding expectations, according to Dennis Fill, chairman and CEO. HDI 1000 will begin shipping this quarter.

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.